These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

366 related articles for article (PubMed ID: 25609203)

  • 1. Paracrine SDF-1α signaling mediates the effects of PSCs on GEM chemoresistance through an IL-6 autocrine loop in pancreatic cancer cells.
    Zhang H; Wu H; Guan J; Wang L; Ren X; Shi X; Liang Z; Liu T
    Oncotarget; 2015 Feb; 6(5):3085-97. PubMed ID: 25609203
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Paracrine HGF promotes EMT and mediates the effects of PSC on chemoresistance by activating c-Met/PI3K/Akt signaling in pancreatic cancer in vitro.
    Xu J; Liu S; Yang X; Cao S; Zhou Y
    Life Sci; 2020 Dec; 263():118523. PubMed ID: 33039386
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Secretion of fibronectin by human pancreatic stellate cells promotes chemoresistance to gemcitabine in pancreatic cancer cells.
    Amrutkar M; Aasrum M; Verbeke CS; Gladhaug IP
    BMC Cancer; 2019 Jun; 19(1):596. PubMed ID: 31208372
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Co-targeting of CXCR4 and hedgehog pathways disrupts tumor-stromal crosstalk and improves chemotherapeutic efficacy in pancreatic cancer.
    Khan MA; Srivastava SK; Zubair H; Patel GK; Arora S; Khushman M; Carter JE; Gorman GS; Singh S; Singh AP
    J Biol Chem; 2020 Jun; 295(25):8413-8424. PubMed ID: 32358063
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intrinsic chemoresistance to gemcitabine is associated with constitutive and laminin-induced phosphorylation of FAK in pancreatic cancer cell lines.
    Huanwen W; Zhiyong L; Xiaohua S; Xinyu R; Kai W; Tonghua L
    Mol Cancer; 2009 Dec; 8():125. PubMed ID: 20021699
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhancement of the CXCL12/CXCR4 axis due to acquisition of gemcitabine resistance in pancreatic cancer: effect of CXCR4 antagonists.
    Morimoto M; Matsuo Y; Koide S; Tsuboi K; Shamoto T; Sato T; Saito K; Takahashi H; Takeyama H
    BMC Cancer; 2016 May; 16():305. PubMed ID: 27175473
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The histone methyltransferase G9a as a therapeutic target to override gemcitabine resistance in pancreatic cancer.
    Pan MR; Hsu MC; Luo CW; Chen LT; Shan YS; Hung WC
    Oncotarget; 2016 Sep; 7(38):61136-61151. PubMed ID: 27531902
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Galectin-1-driven upregulation of SDF-1 in pancreatic stellate cells promotes pancreatic cancer metastasis.
    Qian D; Lu Z; Xu Q; Wu P; Tian L; Zhao L; Cai B; Yin J; Wu Y; Staveley-O'Carroll KF; Jiang K; Miao Y; Li G
    Cancer Lett; 2017 Jul; 397():43-51. PubMed ID: 28336327
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HES 1 is essential for chemoresistance induced by stellate cells and is associated with poor prognosis in pancreatic cancer.
    Cao F; Li J; Sun H; Liu S; Cui Y; Li F
    Oncol Rep; 2015 Apr; 33(4):1883-9. PubMed ID: 25672829
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Blockade of SDF-1/CXCR4 reduces adhesion-mediated chemoresistance of multiple myeloma cells via interacting with interleukin-6.
    Liu Y; Liang HM; Lv YQ; Tang SM; Cheng P
    J Cell Physiol; 2019 Nov; 234(11):19702-19714. PubMed ID: 30953364
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cancer-associated fibroblasts promote the progression of endometrial cancer via the SDF-1/CXCR4 axis.
    Teng F; Tian WY; Wang YM; Zhang YF; Guo F; Zhao J; Gao C; Xue FX
    J Hematol Oncol; 2016 Feb; 9():8. PubMed ID: 26851944
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CXCL12-CXCR4 signalling axis confers gemcitabine resistance to pancreatic cancer cells: a novel target for therapy.
    Singh S; Srivastava SK; Bhardwaj A; Owen LB; Singh AP
    Br J Cancer; 2010 Nov; 103(11):1671-9. PubMed ID: 21045835
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Integrated stress response is critical for gemcitabine resistance in pancreatic ductal adenocarcinoma.
    Palam LR; Gore J; Craven KE; Wilson JL; Korc M
    Cell Death Dis; 2015 Oct; 6(10):e1913. PubMed ID: 26469962
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pirfenidone inhibits pancreatic cancer desmoplasia by regulating stellate cells.
    Kozono S; Ohuchida K; Eguchi D; Ikenaga N; Fujiwara K; Cui L; Mizumoto K; Tanaka M
    Cancer Res; 2013 Apr; 73(7):2345-56. PubMed ID: 23348422
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SDF-1α upregulation of MMP-2 is mediated by p38 MAPK signaling in pancreatic cancer cell lines.
    Pan F; Ma S; Cao W; Liu H; Chen F; Chen X; Shi R
    Mol Biol Rep; 2013 Jul; 40(7):4139-46. PubMed ID: 23712777
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Asporin promotes pancreatic cancer cell invasion and migration by regulating the epithelial-to-mesenchymal transition (EMT) through both autocrine and paracrine mechanisms.
    Wang L; Wu H; Wang L; Zhang H; Lu J; Liang Z; Liu T
    Cancer Lett; 2017 Jul; 398():24-36. PubMed ID: 28400334
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cellular context-dependent interaction between cancer and stellate cells in hetero-type multicellular spheroids of pancreatic tumor.
    Nam S; Khawar IA; Park JK; Chang S; Kuh HJ
    Biochem Biophys Res Commun; 2019 Jul; 515(1):183-189. PubMed ID: 31133378
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stromal cell-derived factor 1α mediates resistance to mTOR-directed therapy in pancreatic cancer.
    Weekes CD; Song D; Arcaroli J; Wilson LA; Rubio-Viqueira B; Cusatis G; Garrett-Mayer E; Messersmith WA; Winn RA; Hidalgo M
    Neoplasia; 2012 Aug; 14(8):690-701. PubMed ID: 22952422
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stromal cell-derived factor-1/CXCR4 promotes IL-6 production in human synovial fibroblasts.
    Chen HT; Tsou HK; Hsu CJ; Tsai CH; Kao CH; Fong YC; Tang CH
    J Cell Biochem; 2011 Apr; 112(4):1219-27. PubMed ID: 21312239
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Periostin promotes the chemotherapy resistance to gemcitabine in pancreatic cancer.
    Liu Y; Li F; Gao F; Xing L; Qin P; Liang X; Zhang J; Qiao X; Lin L; Zhao Q; Du L
    Tumour Biol; 2016 Nov; 37(11):15283-15291. PubMed ID: 27696296
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.